Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
ArisGlobal has launched XDI, a federated data intelligence platform designed to unify and analyze life sciences data across domains, enabling explainable decision-making at scale.
Angelini Pharma and Quiver Bioscience have entered a multi-year research and licensing agreement to develop AI-driven therapies for genetic epilepsies. The partnership grants Angelini exclusive global rights to future drug targets identified through Quiver’s platform.
MediKarma reported that its Agentic AI platform achieved a 50% A1C improvement rate in a 120-day study with Dallas Endocrinology, leading to a 20,000-unit deployment with Family Health Choice.
Trust AI has introduced Isaac PracticeOS, an AI-based dental practice management system that consolidates billing, scheduling, insurance, and clinical operations into a single platform.
Tennr has appointed Dr. William H. Morris, a former executive at Cleveland Clinic and Google, as its new Chief Medical Officer. He will work with health systems to enhance triage and referral management using the company’s AI technology.
Admanager, powered by Doceree, has introduced the Licensed Content Marketplace, a platform enabling healthcare publishers to license and control their content for AI use, ensuring protection against unauthorized scraping.
Iambic Therapeutics has entered a multi-year collaboration with Takeda to use its AI-driven platform for small molecule drug design in oncology and gastrointestinal research, with potential payments exceeding $1.7 billion.
Robots & Pencils has introduced a three-part thought leadership series titled 'Supply Chain as a Patient Safety System,' authored by Eric Ujvari. The series highlights how applied AI can align healthcare supply performance with patient care demands.
Stellaromics has appointed industry veterans Stacie Weninger and Steve McPhail to its Board of Directors as it expands its Pyxa 3D spatial multi-omics technology.
Exxat announced it has received a minority growth investment from Accel-KKR to support product innovation and expand its reach in healthcare education and workforce development.
Garner Health has raised $118 million in Series D funding led by Kleiner Perkins, bringing its valuation to $1.35 billion. The company plans to expand its AI-driven provider-ranking engine and incentive platform serving over 2.5 million members.
Brainomix has introduced its Brainomix 360 Stroke Next Generation platform at the International Stroke Conference, featuring a new net water uptake capability to enhance stroke assessment using routine CT scans.
Ginkgo Bioworks, in collaboration with OpenAI, demonstrated an autonomous laboratory system powered by GPT-5 that reduced protein synthesis costs by 40% compared to existing methods.
HealthTrackRx has chosen SYNERGEN Health as its revenue cycle management partner to improve operational efficiency and financial performance through AI-enabled technology.
Cognizant and Uniphore have announced a strategic partnership to develop domain-specific AI solutions that combine small language models and AI agents tailored for enterprise workflows. The collaboration will initially target the Life Sciences and Banking and Capital Markets sectors.
Presbyterian Healthcare Services is expanding the GW RhythmX AI Precision Care Platform across its 200 primary care clinicians after a successful pilot that improved efficiency and patient care insights.
Deep EigenMatics has secured the top global ranking for new U.S. patent families in AI drug discovery methods for 2025, surpassing all major pharmaceutical companies in patent output during its first year of operation.
Virtual Science AI has introduced Medical Congress AI, a conversational AI solution that captures and analyzes real-time insights from medical congress events, marking a first in the life sciences industry.
Oracle has introduced the Oracle Life Sciences AI Data Platform, a generative AI-enabled solution designed to unify and analyze large-scale health data to support pharmaceutical, medical device, and research organizations.
XtalPi unveiled its new AI-driven XGlue platform at the 2026 International Symposium on Molecular Glue Drug Discovery in Shanghai, aiming to accelerate systematic discovery of molecular glue therapeutics.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
